Biopharmaceutical Manufacturing, Upstream, Downstream processing news

Headlines

Can Sernova and Evotec’s cell therapy approach result in a functional cure for diabetes?

Sernova and Evotec are teaming up on an implantable beta cell replacement therapy to replace insulin injections for the millions of patients with diabetes.

The Longmont facility. Pic: AGC Biologics.

AGC Biologics adds new viral vector suspension capabilities at US cell & gene facility

AGC Biologics will add viral vector suspension technology and capacity for the development and manufacturing of gene therapies at its commercial-grade campus in Longmont, Colorado.

Bacteriophage producer Locus Biosciences raises $35m in financing

Locus Biosciences says the US$35m in funding it has raised from a mix of old and new investors is further validation of its novel approach to treating bacterial diseases.

WHO validates 11th COVID-19 vaccine

The World Health Organization (WHO) has today issued an emergency use listing (EUL) for Convidecia, a vaccine manufactured by CanSino Biologics, bringing the total number of COVID-19 vaccines validated by the organisation to 11.